132 related articles for article (PubMed ID: 38407508)
41. Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
Fox GM; Albayaty M; Walker JL; Xue H; Darpo B
Anesth Analg; 2021 Jan; 132(1):150-159. PubMed ID: 31913911
[TBL] [Abstract][Full Text] [Related]
42. Exposure-response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters.
Garg A; Li J; Clark E; Knott A; Carrothers TJ; Marier JF; Cortés J; Brewster M; Visich J; Lum B
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1133-41. PubMed ID: 23999693
[TBL] [Abstract][Full Text] [Related]
43. A Thorough QT Study of the Combination Glecaprevir + Pibrentasvir on Cardiac Repolarization in Healthy Subjects.
Oberoi RK; Zhao W; Rosebraugh M; Mensa F; Wang H; Liu W
Clin Ther; 2020 Jul; 42(7):1317-1329. PubMed ID: 32622784
[TBL] [Abstract][Full Text] [Related]
44. Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose.
Darpo B; Geva M; Ferber G; Goldberg YP; Cruz-Herranz A; Mehra M; Kovacs R; Hayden MR
Neurol Ther; 2023 Apr; 12(2):597-617. PubMed ID: 36811812
[TBL] [Abstract][Full Text] [Related]
45. Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study.
Munasinghe W; Stodtmann S; Tolcher A; Calvo E; Gordon M; Jalving M; de Vos-Geelen J; Medina D; Bergau D; Nuthalapati S; Hoffman D; Shepherd S; Xiong H
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1003-1011. PubMed ID: 27709282
[TBL] [Abstract][Full Text] [Related]
46. [Effect of single doses of HX0507 on QTc intervals in healthy people: a phase I safety and tolerability study].
Yi XQ; Li R; Zhang WS; Liu J; Xu J; Liao TZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):868-72. PubMed ID: 23387216
[TBL] [Abstract][Full Text] [Related]
47. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
Mondal SA; Assaf M; Liu L; O'Mara E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
[TBL] [Abstract][Full Text] [Related]
48. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
[TBL] [Abstract][Full Text] [Related]
49. Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
Böttcher M; Düngen HD; Corcea V; Donath F; Fuhr R; Gal P; Mikus G; Trenk D; Coenen M; Pires PV; Maschke C; Aliprantis AO; Besche N; Becker C
Am J Cardiovasc Drugs; 2023 Mar; 23(2):145-155. PubMed ID: 36633816
[TBL] [Abstract][Full Text] [Related]
50. Effect of alectinib on cardiac electrophysiology: results from intensive electrocardiogram monitoring from the pivotal phase II NP28761 and NP28673 studies.
Morcos PN; Bogman K; Hubeaux S; Sturm-Pellanda C; Ruf T; Bordogna W; Golding S; Zeaiter A; Abt M; Balas B
Cancer Chemother Pharmacol; 2017 Mar; 79(3):559-568. PubMed ID: 28243683
[TBL] [Abstract][Full Text] [Related]
51. Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor-mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects.
Darpo B; Zhou M; Bai SA; Ferber G; Xiang Q; Finn A
Clin Ther; 2016 Feb; 38(2):315-26. PubMed ID: 26749217
[TBL] [Abstract][Full Text] [Related]
52. Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia.
Kang D; Ludwig E; Jaworowicz D; Huang H; Fiedler-Kelly J; Cortes J; Ganguly S; Khaled S; Krämer A; Levis M; Martinelli G; Perl A; Russell N; Abutarif M; Choi Y; Yin O
Cancer Chemother Pharmacol; 2021 Apr; 87(4):513-523. PubMed ID: 33415416
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the potential effect of dacomitinib, an EGFR tyrosine kinase inhibitor, on ECG parameters in patients with advanced non-small cell lung cancer.
Tan W; Giri N; Quinn S; Wilner K; Parivar K
Invest New Drugs; 2020 Jun; 38(3):874-884. PubMed ID: 31858327
[TBL] [Abstract][Full Text] [Related]
54. E2027 Cardiac Safety Evaluation With Concentration-Response Modeling of ECG Data to Inform Dose Selection in Studies in Patients With Dementia With Lewy Bodies.
Landry IS; Boyd P; Aluri J; Darpo B; Xue H; Brown R; Reyderman L; Lai R
Alzheimer Dis Assoc Disord; 2022 Jul-Sep 01; 36(3):208-214. PubMed ID: 35622456
[TBL] [Abstract][Full Text] [Related]
55. A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors.
Moore K; Infante JR; Cotreau MM; Wilson L; Strahs AL; Vargo DL; Chadha M
Clin Pharmacol Drug Dev; 2014 Jul; 3(4):284-9. PubMed ID: 27128834
[TBL] [Abstract][Full Text] [Related]
56. Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers.
Topletz-Erickson AR; Mayor JG; Liu HT; Abdulrasool LI; Endres CJ
Drugs R D; 2023 Dec; 23(4):411-419. PubMed ID: 37751113
[TBL] [Abstract][Full Text] [Related]
57. Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study.
Tehranchi R; Pettersson J; Melgaard AE; Seitz F; Valeur A; Maarbjerg SJ
Curr Ther Res Clin Exp; 2022; 96():100668. PubMed ID: 35464292
[TBL] [Abstract][Full Text] [Related]
58. Clinical and Model-Based Evaluation of the Effect of Glasdegib on Cardiac Repolarization From a Randomized Thorough QT Study.
Masters JC; Shaik N; Mendes da Costa L; Hee B; LaBadie RR
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):272-282. PubMed ID: 32790066
[TBL] [Abstract][Full Text] [Related]
59. Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Moore K; Chan JK; Secord AA; Patel MR; Callahan T; Guo W; Zhang ZY
Cancer Chemother Pharmacol; 2019 Apr; 83(4):717-726. PubMed ID: 30680521
[TBL] [Abstract][Full Text] [Related]
60. A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects.
Linnebjerg H; Seger M; Kothare PA; Hunt T; Wolka AM; Mitchell MI
Int J Clin Pharmacol Ther; 2011 Oct; 49(10):594-604. PubMed ID: 21961484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
